Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
21 November 2024
| Name: | MELODIOL GLOBAL HEALTH LIMITED (ME1) | ||||||
| ISIN: | AU0000282840 | ||||||
| Date of Listing: | 20 October 2016 | ||||||
| Date of Delisting: | 28 October 2024 | ||||||
| Former Names: |
|
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 28 October 2024.Legal Status:
ACN: 609 406 911ABN: 89 609 406 911
Registration Date: 20 November 2015
Capital Gains Tax (CGT) Status:
The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| MELODIOL GLOBAL HEALTH LIMITED | 13/06/2023 | |
| CRESO PHARMA LIMITED | 13/06/2023 |
REGISTRY:
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
delisted by ASX under Listing Rule 17.12 | 28/10/2024 |
we understand ASX determined that ME1 was unable or unwilling to comply with, or has broken, Listing Rules 2.6 and 16.4. (rules that mandate fees are to be paid for the quotation of additional securities) | 28/10/2024 |
The company releases a notification of cessation of securities. | 27/09/2024 |
The quoted options exercisable at $15.00 each will expire at 5.00pm WST on 2 November 2024. The listed options are out of the money. | 27/09/2024 |
The company lodges its notice of cessation of securities. | 04/09/2024 |
The securities of Melodiol Global Health Limited will be suspended from Official Quotation at the close of trading on Wednesday, 28 August 2024 under Listing Rule 17.3.1. ASX has determined that ME1 has been unable or unwilling to comply with, or has broken, Listing Rules 2.6 and 16.4. The suspension will continue until ASX is satisfied that ME1 is in compliance with the Listing Rules, including Listing Rules 2.6 and 16.4, and that it is otherwise appropriate for ME1's securities to be reinstated to quotation. | 28/08/2024 |
name changed from Creso Pharma Limited | 13/06/2023 |
delisted by ASX under Listing Rule 17.12 | 28/10/2024 |
we understand ASX determined that ME1 was unable or unwilling to comply with, or has broken, Listing Rules 2.6 and 16.4. (rules that mandate fees are to be paid for the quotation of additional securities) | 28/10/2024 |
The company releases a notification of cessation of securities. | 27/09/2024 |
The quoted options exercisable at $15.00 each will expire at 5.00pm WST on 2 November 2024. The listed options are out of the money. | 27/09/2024 |
The company lodges its notice of cessation of securities. | 04/09/2024 |
The securities of Melodiol Global Health Limited will be suspended from Official Quotation at the close of trading on Wednesday, 28 August 2024 under Listing Rule 17.3.1. ASX has determined that ME1 has been unable or unwilling to comply with, or has broken, Listing Rules 2.6 and 16.4. The suspension will continue until ASX is satisfied that ME1 is in compliance with the Listing Rules, including Listing Rules 2.6 and 16.4, and that it is otherwise appropriate for ME1's securities to be reinstated to quotation. | 28/08/2024 |
name changed from Creso Pharma Limited | 13/06/2023 |
Your browser may reflect a date of printing in American format.
what happends to our shares? do we claim these a a loss on next tax return? or will they relist in the future? | 09/11/2024 12:40:51 |
Any class action against the company of misleading and deceptive conduct | 08/11/2024 16:15:47 |
What will happen to my money invested on this useless company? | 01/11/2024 11:22:28 |
How can I get rid of this useless stock | 29/10/2024 15:34:24 |
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 07/07/2021 | Adam Blumenthal | 32,833,333 | $0.138 | $4,538,059 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| William Lay | Managing Director, CEO | 17/01/2022 |
| Tim Tian | CFO | 01/05/2024 |
| Ben Quirin | Non Exec Director | 10/10/2022 |
| Peter Hatfull | Non Exec Director | 30/11/2022 |
| Boaz Wachtel | Non Exec Director | 22/11/2015 |
| Bruce Linton | Non Exec Director | 17/01/2022 |
| Micheline MacKay | Executive Director | 17/01/2022 |
| Winton Willesee | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Chris Grundy | CFO | 04/12/2017 | 01/05/2024 |
| Jodi Scott | Executive Director | 10/10/2022 | 30/04/2024 |
| James Ellingford | Executive Director | 22/11/2015 | 01/12/2022 |
| Adam Blumenthal | Non Exec Chairman | 22/11/2015 | 10/10/2022 |
| Miri Wernli | Executive Director | 20/10/2016 | 17/03/2021 |
| David Russell | COO | 04/04/2017 | 04/12/2017 |
| Simon Buckingham | Non Exec Director | 20/10/2016 | 01/06/2017 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
